JY
HRMY icon

Jeff Yass’s Harmony Biosciences HRMY Stock Holding History

Jeff Yass’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.01M Buy
110,200
+29,700
+37% +$937K ﹤0.01% 5042
2026
Q1 		$2.25M Sell
80,500
-74,300
-48% -$2.44M ﹤0.01% 5895
2025
Q4 		$5.79M Sell
154,800
-164,000
-51% -$5.39M ﹤0.01% 3792
2025
Q3 		$8.79M Buy
318,800
+75,500
+31% +$2.6M ﹤0.01% 3204
2025
Q2 		$7.69M Buy
243,300
+127,300
+110% +$4.1M ﹤0.01% 3232
2025
Q1 		$3.85M Buy
116,000
+11,000
+10% +$394K ﹤0.01% 4151
2024
Q4 		$3.61M Buy
105,000
+2,700
+3% +$92.8K ﹤0.01% 4117
2024
Q3 		$4.09M Buy
102,300
+56,300
+122% +$1.98M ﹤0.01% 3960
2024
Q2 		$1.39M Sell
46,000
-14,500
-24% -$436K ﹤0.01% 5833
2024
Q1 		$2.03M Buy
60,500
+4,100
+7% +$132K ﹤0.01% 5304
2023
Q4 		$1.82M Sell
56,400
-107,800
-66% -$3.01M ﹤0.01% 5568
2023
Q3 		$5.38M Buy
164,200
+140,500
+593% +$4.88M ﹤0.01% 3393
2023
Q2 		$834K Buy
23,700
+13,600
+135% +$470K ﹤0.01% 7111
2023
Q1 		$330K Sell
10,100
-4,000
-28% -$182K ﹤0.01% 9503
2022
Q4 		$777K Sell
14,100
-14,600
-51% -$803K ﹤0.01% 6738
2022
Q3 		$1.27M Buy
28,700
+200
+0.7% +$9.76K ﹤0.01% 6014
2022
Q2 		$1.39M Buy
+28,500
New +$1.28M ﹤0.01% 5730

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jeff Yass's HRMY Position: Q2 2026 in Review

Jeff Yass increased its Harmony Biosciences (HRMY) stake by 479% in Q2 2026, buying an estimated $3.84M and bringing the position to 147,176 shares worth $5.36M. The position accounts for ﹤0.01% of the portfolio, ranked #4476.

Jeff Yass first reported a position in HRMY in Q1 2021 and has held it in 17 quarters since. 325 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Jeff Yass held 147,176 shares of Harmony Biosciences worth $5.36M as of Q2 2026.
  • Jeff Yass bought 121,775 Harmony Biosciences shares in Q2 2026, an estimated $3.84M.
  • Harmony Biosciences made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #4476 holding.
  • Jeff Yass first reported a position in Harmony Biosciences in Q1 2021 and has held it in 17 quarters since.
  • 325 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.